VR
The company announced its first funding round at the Health 2.0 VentureConnect event in San Francisco yesterday.
New agreements with five different tech companies and research organizations aim to expand and flesh out the digital therapeutics maker's product pipeline.
In a small study, researchers found that 99% of patients given a multi-user version of VR therapy completed the treatment.
NASA stakeholders discuss the potential for technologies supporting astronauts' mental health and cognitive functioning during a mission.
Downing Ventures led the round with participation from Tern PLC, Epic Private Equity and Brighteye Ventures.
Therapeutic VR's efficacy is established — time to tackle practical implementation, scaling, payment
At last week's Connected Health Conference, a panel of VR evangelists turned their eyes toward the bigger hurdles facing VR's potential for success within healthcare.
The funding will also support further development of the technology and new staff hires.
Positive data from the pragmatic study is the clearest evidence yet that in-hospital therapeutic VR could be effective in a live deployment, according to researchers.
Also: Validation data on Osso VR's surgical training tool; Apple seeking health record development experts.
The company exclusively announced to MobiHealthNews its plans to create a tool kit for providers, payers and pharmas.